Katarzyna G. K.
- Country
- Poland
- Department
- II Klinika Radioterapii I Chemioterapii
Research Overview
Data & Insights
Has run more than one trial at 0 of 75 partner sites.
Specializations
Oncology Focus
This investigator specializes in the treatment of non-small cell lung cancer (NSCLC), with particular emphasis on managing locally advanced Stage III unresectable cases.
- Advanced Lung Cancer Treatment
- Stage III NSCLC Management
- Unresectable Tumor Therapy
The research interest extends to innovative therapeutic approaches for patients with specific tumor characteristics.
Immunotherapy Research
The investigator focuses on novel immunotherapy combinations in oncology, particularly exploring the therapeutic potential of durvalumab and domvanalimab in lung cancer treatment.
- Immune Checkpoint Inhibition
- PD-L1 Expression Analysis
- Combination Immunotherapy
Areas of expertise include assessment of tumor biomarkers and immunological responses in cancer therapy.
Multimodal Treatment
The investigator specializes in integrated treatment approaches combining chemoradiation therapy with innovative therapeutic agents for lung cancer patients.
- Combined Modality Treatment
- Platinum-based Therapy
- Treatment Sequencing
Research interests include optimization of concurrent therapeutic strategies in advanced lung cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.